Cargando…
Epigenetic Mechanism of 5-HT/NE/DA Triple Reuptake Inhibitor on Adult Depression Susceptibility in Early Stress Mice
Major depressive disorder (MDD) is a chronic, remitting and debilitating disease and the etiology of MDD is highly complicated that involves genetic and environmental interactions. Despite many pharmacotherapeutic options, many patients remain poorly treated and the development of effective treatmen...
Autores principales: | Meng, Ping, Li, Chunmei, Duan, Sijin, Ji, Shengmin, Xu, Yangyang, Mao, Yutong, Wang, Hongbo, Tian, Jingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968447/ https://www.ncbi.nlm.nih.gov/pubmed/35370730 http://dx.doi.org/10.3389/fphar.2022.848251 |
Ejemplares similares
-
Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
por: Zhu, Haibo, et al.
Publicado: (2021) -
LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain
por: Li, Nannan, et al.
Publicado: (2019) -
Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors
por: Lim, Juhee, et al.
Publicado: (2023) -
The effect of triple reuptake inhibitor toludesvenlafaxine on neurological function in cerebral ischemic rats
por: Sun, Xiaohui, et al.
Publicado: (2023) -
Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)